Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
ω-Agatoxin IVA TFA: Precision Cav2.1 Inhibition in Synaptic
2026-04-25
Explore how ω-Agatoxin IVA TFA advances synaptic transmission research through precise Cav2.1 channel inhibition. This article uniquely bridges molecular pharmacology with neurodevelopmental insight, grounded in cutting-edge literature.
-
Sulfo-NHS-Biotin: Precision Protein Labeling for Cell Surfac
2026-04-24
Sulfo-NHS-Biotin stands out as a water-soluble, amine-reactive protein labeling reagent, enabling highly selective biotinylation of cell surface proteins without membrane penetration. Its robust performance in affinity purification, immunoprecipitation, and cell surface mapping empowers translational researchers with reproducibility and workflow flexibility.
-
Berberrubine chloride: Applied Protocols for Cancer & Metabo
2026-04-24
Berberrubine chloride, a DMSO-soluble isoquinoline alkaloid from APExBIO, empowers cancer and metabolic disease researchers with validated, multi-target workflows. This guide translates breakthrough findings—like urate transporter modulation and pathway inhibition—into optimized, reproducible protocols and troubleshooting strategies.
-
NSC23766 Trihydrochloride: Precision Control of Rac1 in Meta
2026-04-23
Explore the unique role of NSC-23766, a selective Rac GTPase inhibitor, in unraveling Rac1-driven metabolic and cancer pathways. This article delivers a deep analysis of its mechanism, application nuances, and new assay insights for advanced research.
-
Neuroinflammation Drives Allodynia via CGRP/SP-Piezo2 in TN
2026-04-23
Liao et al. uncover a mechanistic link between trigeminal nerve root compression and mechanical allodynia through a CGRP/SP-Piezo2 axis dependent on Ca2+ signaling. Their findings advance understanding of neuroinflammatory pain pathogenesis and highlight new experimental targets for trigeminal neuralgia.
-
Improving In Vitro Evaluation of Anticancer Drug Responses
2026-04-22
Schwartz (2022) critically re-examines how in vitro assays measure anticancer drug responses, distinguishing between relative and fractional viability as metrics of drug efficacy. This work provides practical guidance for optimizing the interpretation of proliferation and cell death in preclinical cancer research.
-
Applied Advances with (-)-Epigallocatechin Gallate in Resear
2026-04-22
Leverage (-)-Epigallocatechin gallate (EGCG) for precise apoptosis, antiangiogenic, and antiviral workflows. This article details experimental protocols, troubleshooting, and actionable insights—anchored in recent peer-reviewed innovations and APExBIO's trusted quality.
-
5-EdU: Redefining S Phase Detection for Translational Oncolo
2026-04-21
This thought-leadership article explores how 5-Ethynyl-2'-deoxyuridine (5-EdU) is transforming cell proliferation assays for translational researchers, with a focus on mechanistic insight, strategic implementation, and clinical relevance. By integrating recent findings on cell cycle regulation in pancreatic cancer and benchmarking against legacy methods, we guide the next generation of tissue regeneration and tumor growth studies.
-
UBR1/UBR2 as Central ER Stress Sensors: Insights into PQC Pa
2026-04-21
This article analyzes recent findings establishing UBR1 and UBR2 as pivotal ER stress sensors and anti-stress factors in mammalian protein quality control. The study advances understanding of the N-degron pathway’s integration with ER-associated degradation and the ubiquitin-proteasome system, with practical implications for dissecting ER stress responses in cell models.
-
New Phenylethanoid Glycosides from Forsythia suspensa: Analy
2026-04-20
This study reports the isolation and structure elucidation of three novel caffeoyl phenylethanoid glycosides (Forsythosides H–J) and six known glycosides, including Forsythoside E, from the fruits of Forsythia suspensa. These findings expand the chemical toolkit available for studying immunometabolic modulation, particularly for researchers interested in PKM2 inhibition and macrophage polarization.
-
Maternal Deltamethrin Exposure Impairs Offspring Memory via
2026-04-20
This study demonstrates that maternal exposure to deltamethrin during pregnancy and lactation impairs hippocampal-dependent learning and memory in male offspring by activating p53-mediated ferroptosis pathways. The findings clarify mechanistic links between environmental toxicants, neuronal loss, and cognitive dysfunction, providing a robust experimental framework for future neuroprotection research.
-
HyperTrap Heparin HP Column: Mechanistic Precision in Cancer
2026-04-19
Discover how the HyperTrap Heparin HP Column delivers unparalleled resolution for complex protein purification, enabling nuanced investigation of cancer stem cell signaling. This article uniquely bridges product chemistry, experimental protocol, and mechanistic insight for translational assay design.
-
Placenta Exosomal miR-519d-3p Drives Immune Imbalance in Pre
2026-04-18
This study reveals that placenta-derived exosomal miR-519d-3p contributes to preeclampsia pathogenesis by promoting immune intolerance through altered T cell differentiation and survival. These mechanistic insights underscore the significance of miRNA-mediated immune modulation at the maternal-fetal interface and suggest new avenues for research into pregnancy complications.
-
Clarithromycin: CYP3A Inhibitor for Drug-Drug Interaction Re
2026-04-17
Clarithromycin is a potent CYP3A inhibitor used in pharmacokinetic studies and drug-drug interaction research. Its validated performance and well-characterized mechanism make it a gold-standard tool for modeling statin metabolism and cardiovascular drug interactions. Reliable workflows depend on its high purity, solubility, and rigorous quality controls.
-
E-64d: Precision Cysteine Protease Inhibition for Cell Death
2026-04-16
E-64d empowers researchers to selectively inhibit intracellular cysteine proteases, enabling rigorous dissection of apoptosis, lysoptosis, and neuroprotection pathways. This article translates the latest mechanistic insights and troubleshooting strategies into actionable workflows, ensuring robust, reproducible results in both cellular and animal models.